TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/08/2025
Back to search
Official data from USPTO
MICROBAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
07/13/2025
Trademark type
Word
Nice classes
5
Filing date
07/20/2015
Registration date
06/28/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/03/2023
Last transaction
07/13/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
09
Owner location
Novara (NO), IT
Examiner
DICKEY, ERICA
Law office
M30
Current location
TMO LAW OFFICE 112
Holders and representatives
Holders
PROBIOTICAL S.P.A.
PROBIOTICAL S.P.A.
Representatives
Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Micro-organisms culture for medical uselactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing microorganisms and cultures of microorganismsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements containing microorganisms and cultures of microorganismsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism; Pharmaceutical products for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesincludingintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans; Microbial and biological preparations for improving the physical well-being of humansreducing inflammation and pain; Supplementsdietary supplementsfor medical use and baby foodall the above containing preparations and products resulting from the processing of microorganismsparticularly metabolites obtained from the processing of probiotic bacterial cultures; Supplementsdietary supplements for medical use and baby foodall the above containing liquidsoliddried or freeze-dried microorganisms or concentrated cultures of probiotic microorganisms; ferments for medical purposesall the foregoing being for medical and veterinary use only
Publications
History of USPTO decisions and trademark events.
47 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/08/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/08/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/28/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/10/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
12/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/10/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/03/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/20/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/07/2023
ES8R
TEAS SECTION 8 RECEIVED
12/27/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/28/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/31/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/31/2016
AMD7
SEC 7 REQUEST FILED
08/01/2016
PAPER RECEIVED
08/01/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
06/28/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2016
PUBO
PUBLISHED FOR OPPOSITION
04/12/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/09/2016
ALIE
ASSIGNED TO LIE
03/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
03/02/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/02/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
03/02/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/28/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/28/2016
ALIE
ASSIGNED TO LIE
01/26/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/13/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/30/2015
GNRT
NON-FINAL ACTION E-MAILED
10/30/2015
CNRT
NON-FINAL ACTION WRITTEN
10/30/2015
DOCK
ASSIGNED TO EXAMINER
10/29/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
07/25/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2015
NWAP
NEW APPLICATION ENTERED
07/23/2015
Continuous trademark protection
Get notified about every new filing that threatens MICROBAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.